Correlation Between Radcom and Evolutionary Genomics

Can any of the company-specific risk be diversified away by investing in both Radcom and Evolutionary Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Radcom and Evolutionary Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Radcom and Evolutionary Genomics, you can compare the effects of market volatilities on Radcom and Evolutionary Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Radcom with a short position of Evolutionary Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Radcom and Evolutionary Genomics.

Diversification Opportunities for Radcom and Evolutionary Genomics

0.0

Correlation Coefficient

Radcom  Evolutionary Genomics

Pay attention - limited upside

The 3 months correlation between Radcom and Evolutionary is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Radcom and Evolutionary Genomics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evolutionary Genomics and Radcom is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Radcom are associated (or correlated) with Evolutionary Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evolutionary Genomics has no effect on the direction of Radcom i.e., Radcom and Evolutionary Genomics go up and down completely randomly.

Pair Corralation between Radcom and Evolutionary Genomics

If you would invest  1,312  in Radcom on May 17, 2025 and sell it today you would lose (32.00) from holding Radcom or give up 2.44% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	96.83%
Values	Daily Returns

Radcom  vs.  Evolutionary Genomics

Radcom

Risk-Adjusted Performance

Weakest

Over the last 90 days Radcom has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy fundamental indicators, Radcom is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Evolutionary Genomics

Risk-Adjusted Performance

Weakest

Over the last 90 days Evolutionary Genomics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Evolutionary Genomics is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Radcom and Evolutionary Genomics

The main advantage of trading using opposite Radcom and Evolutionary Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Radcom position performs unexpectedly, Evolutionary Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evolutionary Genomics will offset losses from the drop in Evolutionary Genomics' long position.

The idea behind Radcom and Evolutionary Genomics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.